These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7552078)

  • 1. Monoclonal antibody therapy of inflammatory rheumatic diseases.
    Breedveld FC; van der Lubbe PA
    Br Med Bull; 1995 Apr; 51(2):493-502. PubMed ID: 7552078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New directions for biological therapy in rheumatoid arthritis.
    Elliott MJ; Maini RN
    Int Arch Allergy Immunol; 1994; 104(2):112-25. PubMed ID: 8199454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic agents in the therapy of inflammatory rheumatic diseases, including therapeutic antibodies, cytokines, and cytokine antagonists.
    Kalden JR
    Curr Opin Rheumatol; 1994 May; 6(3):281-6. PubMed ID: 8060762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody therapy in rheumatic disease.
    Pitzalis C; Choy E; Kingsley G
    Presse Med; 1994 Mar; 23(11):532-9. PubMed ID: 8022742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic agents in the treatment of inflammatory rheumatic diseases.
    Kalden JR; Manger B
    Curr Opin Rheumatol; 1998 May; 10(3):174-8. PubMed ID: 9608318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monoclonal antibodies for treating autoimmune diseases].
    Takeno M; Sakane T
    Nihon Rinsho; 1997 Jun; 55(6):1543-8. PubMed ID: 9200946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic agents in the treatment of inflammatory rheumatic diseases.
    Kalden JR; Manger B
    Curr Opin Rheumatol; 1995 May; 7(3):191-7. PubMed ID: 7612410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action.
    Bayry J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Nat Clin Pract Rheumatol; 2007 May; 3(5):262-72. PubMed ID: 17471245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic agents in the treatment of inflammatory rheumatic diseases.
    Kalden JR; Manger B
    Curr Opin Rheumatol; 1997 May; 9(3):206-12. PubMed ID: 9204255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on therapeutic monoclonal antibodies.
    Bussel JB; Giulino L; Lee S; Patel VL; Sandborg C; Stiehm ER
    Curr Probl Pediatr Adolesc Health Care; 2007 Apr; 37(4):118-35. PubMed ID: 17434008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monoclonal antibodies as an immunotherapy of rheumatoid arthritis].
    Abe T; Takeuchi T
    Nihon Rinsho; 1998 Mar; 56(3):776-81. PubMed ID: 9549372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New therapeutic approaches in autoimmune rheumatic diseases, with special emphasis on rheumatoid arthritis.
    Kalden JR; Manger B
    Br J Rheumatol; 1995 Mar; 34(3):193-6. PubMed ID: 7728390
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic monoclonal antibodies.
    Choy EH; Panayi GS; Kingsley GH
    Br J Rheumatol; 1995 Aug; 34(8):707-15. PubMed ID: 7551652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The production of chemotactic cytokines in an allogeneic response. The role of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-3.
    Lukacs NW; Kunkel SL; Burdick MD; Strieter RM
    Am J Pathol; 1993 Oct; 143(4):1179-88. PubMed ID: 7692733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic human monoclonal antibodies in inflammatory diseases.
    Kotsovilis S; Andreakos E
    Methods Mol Biol; 2014; 1060():37-59. PubMed ID: 24037835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of inflammatory diseases with a monoclonal antibody to intercellular adhesion molecule 1.
    Rothlein R; Jaeger JR
    Ciba Found Symp; 1995; 189():200-8; discussion 208-11. PubMed ID: 7587634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology and therapeutic potential of monoclonal antibody treatment in rheumatoid arthritis.
    Choy EH
    Drugs Aging; 1998 Feb; 12(2):139-48. PubMed ID: 9509292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting interleukin-6 in pediatric rheumatic diseases.
    De Benedetti F
    Curr Opin Rheumatol; 2009 Sep; 21(5):533-7. PubMed ID: 19593141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New immunologic treatment of rheumatoid arthritis].
    Sany J
    Rev Rhum Ed Fr; 1993 Mar; 60(3):229-39. PubMed ID: 8293009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of systemic inflammatory diseases in childhood: "Lessons from clinical trials of anti-cytokine monoclonal antibodies for Kawasaki disease, systemic onset juvenile idiopathic arthritis, and cryopyrin-associated periodic fever syndrome".
    Yokota S; Kikuchi M; Nozawa T; Kanetaka T; Sato T; Yamazaki K; Sakurai N; Hara R; Mori M
    Mod Rheumatol; 2015 Jan; 25(1):1-10. PubMed ID: 24842480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.